Pharmacotherapy is the cornerstone of practice for many psychiatrists today. The busy clinician may have only 15 minutes with each patient to prescribe, monitor, and initiate changes in the medication regimen.Yet even as the field of psychiatry evolves, the doctor-patient relationship still plays a critical role in clinical course and outcome of treatment. This invaluable book shows prescribing clinicians how to make the most of limited time with patients to establish a strong therapeutic relationship and maximize treatment adherence. Concise guidelines are provided for rapidly building the therapeutic alliance; conducting a thorough diagnostic interview; eliciting open, honest reports from patients on the effects of medications; and helping patients address interpersonal issues that may be hindering treatment. Also explored are ways to enhance collaboration between professionals when the treatment is split between a psychotherapist and a prescribing physician. Demonstrating how to put the principles discussed into daily practice, the book includes a wealth of clearly presented case examples.
Many clients in psychotherapy today are also taking psychiatric medications. In the jigsaw puzzle of patient care, the prescribing clinician and the therapist each play a crucial role in monitoring medication effects and facilitating overall treatment success. Designed primarily for psychiatrists, this invaluable book demonstrates how to build strong working relationships with patients even when one is 'only prescribing.' Guidelines are provided to help the clinician rapidly develop the therapeutic alliance, conduct a thorough diagnostic interview, elicit open, honest reports from patients on the effects of medications, and understand issues that may be hindering adherence. For nonpsychiatrists, the book offers a deeper understanding of the role of the psychiatrist and of medications in the lives of their patients. Readers on either side of the disciplinary divide will appreciate the book's wealth of case examples, attention to both medical and psychosocial concerns in pharmacotherapy, and practical recommendations for managing split treatment effectively. Special attention is given to the importance of information-sharing around such issues as changes in the medication regimen or in the patient's clinical presentation.
|Publisher:||Guilford Publications, Inc.|
|Edition description:||Second Edition|
|Product dimensions:||6.12(w) x 9.25(h) x (d)|
About the Author
G. Alan Marlatt, PhD, until his death in 2011, was Director of the Addictive Behaviors Research Center and Professor of Psychology at the University of Washington. For over 30 years, Dr. Marlatt conducted pioneering work on understanding and preventing relapse in substance abuse treatment and was a leading proponent of the harm reduction approach to treating addictive behaviors. He was a recipient of honors including the Jellinek Memorial Award for outstanding contributions to knowledge in the field of alcohol studies, the Robert Wood Johnson Foundation's Innovators Combating Substance Abuse Award, the Research Society on Alcoholism's Distinguished Researcher Award, and the Career/Lifetime Achievement Award from the Association for Behavioral and Cognitive Therapies.
Dennis M. Donovan, PhD, is Director of the Alcohol and Drug Abuse Institute, Professor in the Department of Psychiatry and Behavioral Sciences, and Adjunct Professor in the Department of Psychology at the University of Washington. He has published extensively in the area of substance abuse and addictive behaviors, with research funding from the National Institute on Alcohol Abuse and Alcoholism and the National Institute on Drug Abuse. He has served on the editorial boards of the Journal of Studies on Alcohol, Psychology of Addictive Behaviors, and Addiction. A member of a number of national professional organizations, Dr. Donovan is past president of the Society of Psychologists in Addictive Behaviors, and is a Fellow of Division 50 (Division on Addictions) of the American Psychological Association.
Table of Contents1. Relapse Prevention for Alcohol and Drug Problems, G. Alan Marlatt and Katie Witkiewitz
2. Relapse Prevention among Diverse Populations, Arthur W. Blume and Berenice García de la Cruz
3. Treating Alcohol Problems, Ronald M. Kadden and Ned L. Cooney
4. Relapse Prevention for Smoking, Saul Shiffman, Jon Kassel, Chad Gwaltney, and Dennis McChargue
5. Relapse Prevention for Stimulant Dependence, Kathleen M. Carroll and Richard A. Rawson
6. Relapse Prevention for Opioid Dependence, Nancy A. Haug, James L. Sorensen, Valerie Gruber, and Yong S. Song
7. Relapse Prevention for Cannabis Abuse and Dependence, Roger A. Roffman and Robert S. Stephens
8. Relapse Prevention for Abuse of Club Drugs, Hallucinogens, Inhalants, and Steroids, Jason R. Kilmer, Jessica M. Cronce, and Rebekka S. Palmer
9. Relapse Prevention for Eating Disorders and Obesity, R. Lorraine Collins
10. Treatment of Gambling Disorders, Howard J. Shaffer and Debi A. LaPlante
11. Enhancing the Relapse Prevention Model for Sex Offenders: Adding Recidivism Risk Reduction Therapy to Target Offenders' Dynamic Risk Needs, Jennifer G. Wheeler, William H. George, and Susan A. Stoner
12. Relapse Prevention for Sexually Risky Behaviors, Tina M. Zawacki, Susan A. Stoner, and William H. George